Sinolinks Medical Innovation

Anrei medical (hz)co.,ltd, a US wholly owned and FDA registered enter-prise, was founded 2006. The company has been developing disposable medical devices for use in a variety of minimally invasive procedures since inception and is a high-tech company vertically integrated in the areas of research and development, manufacturing, distribution and customer service.
In the end of 2016, Anrei successfully introduce the C-Bridge capital in order to boost the domestic market expansion and overseas development.
Today, we have full range of Endoscopic accessory products' manufacturing line completely with the lSO13485 certification. Over 20 productsfamily could be sale in worldwide with the CFDA, CE mark, which cover China, Asia, Europe, North America and Africa.

Sinolinks Medical Innovation Inc., founded in 2004, has good ability on R&D and production, base in the field of surgical consumables. Except the strong R&D capabilities, Sinolinks has acquired 55 patents, including 7 invention patents, 41 utility model patents and 7 appearance patents. In terms of production, it has a 100,000-level clean production workshop of 1,500 square meters.
A two-stage reverse osmosis purified water system, an oil-free anhydrous air system and a constant temperature and humidity warehouse of 1,500 square meters. Currently, Sinolinks obtains CFDA, CE and FDA certificate. Sinolinks has nearly 1,000 domestic customers, and overseas customers ranged in Europe, America and Asia. Sinolinks was acquired by Anrei Medical Device (Tianjin) CO.,Ltd. in 2018 and became its subsidiary.

Total Customer Satisfaction

Quality innovates by promoting continual improvement and regulatory compliance by using teamwork with our customers and our employees to strive for on time delivery that is defect free.